PROTEOMICS SHARED RESOURCE Timothy Haystead, Ph.D., Director The Proteomics Shared Resource provides state-of-the-art instrumentation and methods to members of the Programs of the Duke Comprehensive Cancer Center. The Facility houses two state of the art mass spectrometers, two automated Edman sequenators, two HPLCs, two FPLCs and an automated tryptic digestion peptide extraction workstation. The primary use of the mass spectrometers is in the identification of proteins and peptides. The ABI MALDI-TOF-TOF instrument enables high throughput protein and peptide identification at a very sensitive level (~fmol). Identifications of analyzed proteins arc carried out by peptide mass finger printing and MS/MS searches. The Facility also houses an ABI QSTAR nano spray mass spectrometer for high sensitivity de novo sequencing of peptides, With the development of the FASTS and TFASTS algorithms by the Haystead laboratory we also offer the unique capability of multipeptide de novo sequence searches of the databases. This service is particularly useful for cross-species analysis with short peptide sequences and searching of poorly annotated DNA databases. Both mass spectrometers can be used to identify post-translational modifications on proteins and peptides, in particular phosphorylation sites using neutral loss (MALDI) or precursor ion scanning (electrospray) methods. Conventional Edman based N terminal sequencing is also available in the Facility for the characterization of recombinant proteins and phosphorylation sites which have been labeled with 32P-orthophosphate. The Facility also provides front-end support both in the form of protein and peptide purification instrumentation (the HPLCs and FPLCs) as well as consultation services. Consults usually revolve around strategies for protein isolation and compatibility of experimental procedures with analysis of proteins and peptides by mass spectrometry.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014236-34
Application #
7726665
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2008-01-01
Budget End
2008-12-31
Support Year
34
Fiscal Year
2008
Total Cost
$62,196
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Lu, Min; Sanderson, Sydney M; Zessin, Amelia et al. (2018) Exercise inhibits tumor growth and central carbon metabolism in patient-derived xenograft models of colorectal cancer. Cancer Metab 6:14
Qian, Danwen; Liu, Hongliang; Wang, Xiaomeng et al. (2018) Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival. Int J Cancer :
Ashcraft, Kathleen A; Choudhury, Kingshuk Roy; Birer, Sam R et al. (2018) Application of a Novel Murine Ear Vein Model to Evaluate the Effects of a Vascular Radioprotectant on Radiation-Induced Vascular Permeability and Leukocyte Adhesion. Radiat Res 190:12-21
Ong, Cecilia T; Campbell, Brittany M; Thomas, Samantha M et al. (2018) Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database. Ann Surg Oncol 25:2249-2260
Duan, Bensong; Hu, Jiangfeng; Liu, Hongliang et al. (2018) Genetic variants in the platelet-derived growth factor subunit B gene associated with pancreatic cancer risk. Int J Cancer 142:1322-1331
Wu, Mengxi; Huang, Po-Hsun; Zhang, Rui et al. (2018) Circulating Tumor Cell Phenotyping via High-Throughput Acoustic Separation. Small 14:e1801131
Vlahovic, Gordana; Meadows, Kellen L; Hatch, Ace J et al. (2018) A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer. Oncologist 23:782-790
Xu, Yinghui; Liu, Hongliang; Liu, Shun et al. (2018) Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer. Int J Cancer 143:2400-2408
Feng, Yun; Wang, Yanru; Liu, Hongliang et al. (2018) Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer. Mol Carcinog 57:216-224
Naqvi, Ibtehaj; Gunaratne, Ruwan; McDade, Jessica E et al. (2018) Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis. Mol Ther 26:1020-1031

Showing the most recent 10 out of 513 publications